Inventor
BENJAMIN CHRISTOPHER D
US15 patents
⚠️ This page may combine multiple inventors who share the name “BENJAMIN CHRISTOPHER D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BIOGEN INC
8 patentsUS5925351AJul 20, 1999
Soluble lymphotoxin-β receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease
BIOGEN INC78 citations97
US6669941B1Dec 30, 2003
Soluble lymphotoxin-β receptor as a therapeutic agent for treating TH-1 cell-associated autoimmune disease
BIOGEN INC42 citations96
US6403087B1Jun 11, 2002
Soluble lymphotoxin-β receptors as therapeutic agents for the treatment of immunological disease
BIOGEN INC52 citations96
US6252043B1Jun 26, 2001
Vascular cell adhesion molecule (VCAM) polypeptides
BIOGEN INC47 citations94
US5367056ANov 22, 1994
Endothelial cell-leukocyte adhesion molecules (ELAMs) and molecules involved in leukocyte adhesion (MILAs)
BIOGEN INC50 citations94
US5272263ADec 21, 1993
DNA sequences encoding vascular cell adhesion molecules (VCAMS)
BIOGEN INC72 citations94
US6323027B1Nov 27, 2001
Common gamma chain monoclonal antibody blocking agents
BIOGEN INC39 citations92
US6307025B1Oct 23, 2001
VCAM fusion proteins and DNA coding therefor
BIOGEN INC35 citations91
BIOGEN IDEC INC
5 patentsUS7001598B2Feb 21, 2006
Anti-lymphotoxin-beta receptor antibodies as anti-tumor agents
BIOGEN IDEC INC67 citations98
US6770745B2Aug 3, 2004
Common gamma chain blocking agents
BIOGEN IDEC INC24 citations92
US7459537B2Dec 2, 2008
Anti-lymphotoxin-β receptor antibodies as anti-tumor agents
BIOGEN IDEC INC11 citations84
US7427403B2Sep 23, 2008
Methods for inhibiting lymphotoxin β receptor signalling
BIOGEN IDEC INC9 citations84
US7951371B2May 31, 2011
Soluble lymphotoxin-β receptor fusion protein and methods for inhibiting lymphotoxin β-receptor signaling
BIOGEN IDEC INC2 citations62